A citation-based method for searching scientific literature

Hala Ahmadieh, Nisrine Ghazal, Sami T Azar. Diabetes Metab Syndr Obes 2017
Times Cited: 6







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Volker Vallon, Maria Gerasimova, Michael A Rose, Takahiro Masuda, Joseph Satriano, Eric Mayoux, Hermann Koepsell, Scott C Thomson, Timo Rieg. Am J Physiol Renal Physiol 2014
266
33

Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
Seok Joon Shin, Sungjin Chung, Soo Jung Kim, Eun-Mi Lee, Young-Hye Yoo, Ji-Won Kim, Yu-Bae Ahn, Eun-Sook Kim, Sung-Dae Moon, Myung-Jun Kim,[...]. PLoS One 2016
82
33

Active sugar transport in health and disease.
E M Wright, B A Hirayama, D F Loo. J Intern Med 2007
403
33


Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, Gurvan Queniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy J Malaisse,[...]. Nat Med 2015
390
33

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
33

SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
268
33


Sodium-glucose cotransporter inhibition prevents oxidative stress in the kidney of diabetic rats.
Horacio Osorio, Israel Coronel, Abraham Arellano, Ursino Pacheco, Rocío Bautista, Martha Franco, Bruno Escalante. Oxid Med Cell Longev 2012
65
33

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.
Hassan Rahmoune, Paul W Thompson, Joanna M Ward, Chari D Smith, Guizhu Hong, John Brown. Diabetes 2005
506
33

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
33

SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
91
33

Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury.
Selim Fakhruddin, Wael Alanazi, Keith E Jackson. J Diabetes Res 2017
106
16

The missing link: a single unifying mechanism for diabetic complications.
T Nishikawa, D Edelstein, M Brownlee. Kidney Int Suppl 2000
288
16

Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Usha Panchapakesan, Kate Pegg, Simon Gross, Muralikrishna Gangadharan Komala, Harshini Mudaliar, Josephine Forbes, Carol Pollock, Amanda Mather. PLoS One 2013
169
16

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.
L Zanoli, A Granata, P Lentini, S Rastelli, P Fatuzzo, F Rapisarda, P Castellino. ScientificWorldJournal 2015
22
16

Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
H Grønbaek, I Vogel, R Osterby, I Lancranjan, A Flyvbjerg, H Orskov. Kidney Int 1998
28
16

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
Anthony H Barnett, Ambrish Mithal, Jenny Manassie, Russell Jones, Henning Rattunde, Hans J Woerle, Uli C Broedl. Lancet Diabetes Endocrinol 2014
353
16

Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat.
S Vestri, M M Okamoto, H S de Freitas, R Aparecida Dos Santos, M T Nunes, M Morimatsu, J C Heimann, U F Machado. J Membr Biol 2001
135
16

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters in Patients With Type 2 Diabetes: A Chart-Based Analysis.
Hisayuki Katsuyama, Hidetaka Hamasaki, Hiroki Adachi, Sumie Moriyama, Akiko Kawaguchi, Akahito Sako, Shuichi Mishima, Hidekatsu Yanai. J Clin Med Res 2016
22
16

Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats.
Silvania da Silva Teixeira, Ana C Panveloski-Costa, Aline Carvalho, Fabiana P Monteiro Schiavon, Any de Castro Ruiz Marque, Raquel S Campello, Roberto B Bazotte, Maria T Nunes. Physiol Rep 2016
11
16




Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl,[...]. Circulation 2014
732
16



Renal hyperfiltration related to diabetes mellitus and obesity in human disease.
Alexa N Sasson, David Zi Cherney. World J Diabetes 2012
102
16

Hyperglycaemia--pathophysiological aspects at the cellular level.
G Wolf, F Thaiss. Nephrol Dial Transplant 1995
31
16


Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.
Hiddo J L Heerspink, Mehul Desai, Meg Jardine, Dainius Balis, Gary Meininger, Vlado Perkovic. J Am Soc Nephrol 2017
191
16

A glimpse of various pathogenetic mechanisms of diabetic nephropathy.
Yashpal S Kanwar, Lin Sun, Ping Xie, Fu-You Liu, Sheldon Chen. Annu Rev Pathol 2011
414
16

Glucose transporters of the glomerulus and the implications for diabetic nephropathy.
C W Heilig, F C Brosius, D N Henry. Kidney Int Suppl 1997
28
16

Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury.
Robert Faulhaber-Walter, Limeng Chen, Mona Oppermann, Soo Mi Kim, Yuning Huang, Noriyuki Hiramatsu, Diane Mizel, Hiroshi Kajiyama, Patricia Zerfas, Josephine P Briggs,[...]. J Am Soc Nephrol 2008
77
16


Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
Horacio Osorio, Israel Coronel, Abraham Arellano, Martha Franco, Bruno Escalante, Rocío Bautista. Diabetes Res Clin Pract 2012
20
16

The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
Florian Gembardt, Christoph Bartaun, Natalia Jarzebska, Eric Mayoux, Vladimir T Todorov, Bernd Hohenstein, Christian Hugo. Am J Physiol Renal Physiol 2014
120
16

Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.
V Vallon, K Richter, R C Blantz, S Thomson, H Osswald. J Am Soc Nephrol 1999
228
16

Oxidative stress induces claudin-2 nitration in experimental type 1 diabetic nephropathy.
Eduardo Molina-Jijón, Rafael Rodríguez-Muñoz, María del Carmen Namorado, José Pedraza-Chaverri, José L Reyes. Free Radic Biol Med 2014
33
16

Role of the renin angiotensin system in diabetic nephropathy.
Tanuj Chawla, Deepika Sharma, Archana Singh. World J Diabetes 2010
52
16

Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Sayaka Maeda, Takanori Matsui, Masayoshi Takeuchi, Sho-ichi Yamagishi. Diabetes Metab Res Rev 2013
54
16

Pathogenesis of diabetic nephropathy.
Zemin Cao, Mark E Cooper. J Diabetes Investig 2011
90
16

Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation.
Nobutaka Nakamura, Takanori Matsui, Yuji Ishibashi, Sho-Ichi Yamagishi. Diabetol Metab Syndr 2015
41
16

Renal function in relation to metabolic control in children with diabetes of different duration.
G Dahlquist, A Aperia, O Broberger, B Persson, P Wilton. Acta Paediatr Scand 1983
29
16

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.
James F List, Vincent Woo, Enrique Morales, Weihua Tang, Fred T Fiedorek. Diabetes Care 2009
457
16

The renal hemodynamic basis of diabetic nephropathy.
G T O'Bryan, T H Hostetter. Semin Nephrol 1997
80
16

The link between hyperglycaemia and diabetic nephropathy.
R G Larkins, M E Dunlop. Diabetologia 1992
183
16

T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.
T Adachi, K Yasuda, Y Okamoto, N Shihara, A Oku, K Ueta, K Kitamura, A Saito, I Iwakura, Y Yamada,[...]. Metabolism 2000
62
16

Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion.
Andrew T Hattersley, Bernard Thorens. N Engl J Med 2015
27
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.